What is Epilepsy? Market Dynamic of Epilepsy

Epilepsy is a brain disorder in which a person has repeated seizures over time. Seizures are episodes of uncontrolled and abnormal firing of brain cells that may cause changes in attention or behavior.

Different kinds of seizures are common to each category of epilepsy, according to the CDC. Generalized seizures vary in severity: Absence seizures may cause a person to stare off into space or blink rapidly, while tonic-clonic seizures cause muscle jerks and loss of consciousness. Focal seizures, on the other hand, might cause a person to experience a strange taste or smell, or act dazed and unable to respond to questions.

The Centers for Disease Control and Prevention (CDC) estimates that 3.4 million people in the United States have active epilepsy. While symptoms of epilepsy may vary among cases, the disorder always causes seizures, which are periods of sudden irregular electrical activity in the brain that can affect a person's behavior.

Are you interested to learn more about Epilepsy, get PDF Brochure study here

Image Credit: Focal epilepsy is a result of electrical instability in one area of the brain while generalized epilepsy involves electrical instabilities in many areas of the brain. (Image credit: Shutterstock)

According to healthline, each year 150,000 Americans are identified with central nervous system disorder and every 1 in 26 U.S. people are diagnosed with this disease. After migraine, stroke and Alzheimer, Epilepsy is the fourth most common neurological disease.

Healthy people may have seizures under certain circumstances. If the seizures have a known cause, the condition is referred to as secondary or symptomatic epilepsy. Some of the more common causes include the following:

Tumor
Chemical imbalance such as low blood sugar or sodium
Head injuries
Certain toxic chemicals or drugs of abuse
Alcohol withdrawal
Birth injuries
Abnormal blood vessels in the brain
Other illness that damages or destroys brain tissue

Market Dynamic Epilepsy –

The high susceptibility rate of attaining epilepsy among the elderly is projected to drive market demand. As per the 2018 study in the Neuroepidemiology Journal, the prevalence rate of epilepsy among individuals older than 60 was 7.7 per 1000. Moreover, brain injuries which can trigger post-traumatic epilepsy (PTE) and post-traumatic seizure (PTS) can fuel the demand in the epilepsy market.

Developing economies in Africa offer a prime opportunity for investment in the market. According to a report by the World Health Organization (WHO) in 2017, nearly 80% of the patient population with epilepsy live in middle- and low-income countries. Manufacturers of epileptic drugs can capitalize on the opportunity to invest and establish facilities to cater to the growing demand.

APAC epilepsy market is set to touch a valuation of USD 2,046.57 million by 2023 due to high incidence of the disorder registered in the region. In addition, countries of India, South Korea, and China emerging as viable destinations for testing and development of novel drugs can spur market demand over the forecast period.

Europe is expected to exhibit 8.31% CAGR over the forecast period. Increased investment in research and development of effective drugs to treat epilepsy coupled with high incidence of the disorder are factors projected to drive regional market growth exponentially.

References:

https://www.livescience.com/34723-epilepsy-symptoms-and-treatment.html

https://www.emedicinehealth.com/epilepsy/article_em.htm

https://www.theinsightpartners.com/reports/epilepsy-market/